Cite
Assfalg R, Knoop J, Hoffman KL, et al. Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial. Diabetologia. 2021;64(5):1079-1092doi: 10.1007/s00125-020-05376-1.
Assfalg, R., Knoop, J., Hoffman, K. L., Pfirrmann, M., Zapardiel-Gonzalo, J. M., Hofelich, A., Eugster, A., Weigelt, M., Matzke, C., Reinhardt, J., Fuchs, Y., Bunk, M., Weiss, A., Hippich, M., Halfter, K., Hauck, S. M., Hasford, J., Petrosino, J. F., Achenbach, P., Bonifacio, E., & Ziegler, A. G. (2021). Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial. Diabetologia, 64(5), 1079-1092. https://doi.org/10.1007/s00125-020-05376-1
Assfalg, Robin, et al. "Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial." Diabetologia vol. 64,5 (2021): 1079-1092. doi: https://doi.org/10.1007/s00125-020-05376-1
Assfalg R, Knoop J, Hoffman KL, Pfirrmann M, Zapardiel-Gonzalo JM, Hofelich A, Eugster A, Weigelt M, Matzke C, Reinhardt J, Fuchs Y, Bunk M, Weiss A, Hippich M, Halfter K, Hauck SM, Hasford J, Petrosino JF, Achenbach P, Bonifacio E, Ziegler AG. Oral insulin immunotherapy in children at risk for type 1 diabetes in a randomised controlled trial. Diabetologia. 2021 May;64(5):1079-1092. doi: 10.1007/s00125-020-05376-1. Epub 2021 Jan 30. PMID: 33515070; PMCID: PMC8012335.
Copy
Download .nbib